1月16日上午,港股三叶草生物涨超5%,三叶草生物新冠疫苗预计2023年第一季度启动商业化上市。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.